Vcanbio Cell&Gene Engineering Corp.,Ltd’s Net Profit Dropped 41.7% in First Three Quarters of 2022

Vcanbio Cell&Gene Engineering Corp.,Ltd (中源协和细胞基因工程股份有限公司) (600645.SH) reported a net profit of 113.5 million yuan in the first three quarters of 2022, down 41.7% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, up 1.4% year-on-year.

At the end of the reporting period, it had 5.2 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 30.5%.